Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $25,466,182 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 170 grants at over 100 hospitals in 29 countries.

Baylor College of Medicine/Texas Children's Hospital - $200,000
$200,000.00
December 2015
Targeting DIPGs through Super-activation of Steroid Receptor Co-activators: An in vivo Study in Patient-derived Intra-brain Stem Xenograft Mouse Models

Children's National Health System and Children's Research Institute - $125,000
$125,000.00
December 2015
Comprehensive Molecular-Based Cross-Species Comparison of DIPG Biology

Boston Children's Hospital - $110,000
$110,000.00
December 2015
Enabling epigenetic therapies by exploring DIPG chromatin sensitivities

UCL Institute of Child Health - $200,000
$200,000.00
December 2015
T-cell based immunotherapy for DIPG.

Dana Farber Cancer Institute - $82,863
$82,863.00
December 2015
Discovering novel epigenetic dependencies in Diffuse Intrinsic Pontine Glioma

VU University Medical Center - $92,950
$92,950.00
November 2015
Liquid Biopsies for the Monitoring of Diffuse Intrinsic Pontine Glioma.

Children's Cancer Institute - $145,341
$145,341.00
November 2015
Fenretinide, a novel agent targeting RTK/PI3K/AKT network for the treatment of Diffuse Intrinsic Pontine Glioma.

Cincinnati Children's Hospital Medical Center - $200,000
$200,000.00
October 2015
Intra-tumoral heterogeneity in diffuse intrinsic pontine and midline high-grade gliomas

The Hospital for Sick Children - $190,905
$190,905.00
October 2015
Mitochondrial DNA alterations and their potential as a novel therapeutic target in DIPG

Children's National Medical Center - $200,000
$200,000.00
October 2015
Evaluating TORC1/2 kinase inhibition in murine and nonhuman primate (NHP) models

European DIPG Registry - $445,870.12
$445,870.00
September 2015
European DIPG Registry.

Institute of Cancer Research - $99,470
$99,470.00
September 2015
The Evolutionary Dynamics of Diffuse Intrinsic Pontine Glioma.

Stanford University Medical Center - $200,000
$200,000.00
September 2015
Targeting neuronal activity-regulated DIPG infiltration

International DIPG Registry - $699,935
$699,935.00
August 2015
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry

Ann & Robert H. Lurie Children’s Hospital of Chicago - $50,000
$50,000.00
April 2015
Increased Tenascin-C (TNC) protein expression in tumor tissue and CSF in DIPG patients